1. AB0879 Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Paediatric Patients from Two To Less than Eighteen Years of Age with Juvenile Idiopathic Arthritis. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Hazra, A.; Wang, R.; Mebus, C.; Alvey, C.; Lamba, M.; Krishnaswami, S.; Conte, U.; Wang, M.; Tzaribachev, N.; Foeldvari, I.; Horneff, G.; Kingsbury, D.; Koskova, E.; Smolewska, E.; Vehe, R.K.; Zuber, Z.; Martini, A.; Lovell, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0178 Estimated Medical Expenditures among Patients with Rheumatoid Arthritis Undergoing Treatment with Tofacitinib, an Oral Janus Kinase Inhibitor. (10th June 2014) Authors: Rendas-Baum, R.; Kosinski, M.; Singh, A.; Mebus, C.; Wilkinson, B.; Riese, R.; Wallenstein, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0163 Evaluation of Influenza and Pneumococcal Vaccine Responses in Rheumatoid Arthritis Patients Using Tofacitinib. (23rd January 2014) Authors: Winthrop, K. L.; Neal, J.; Hrycaj, P.; Soma, K.; Wilkinson, B.; Hodge, J.; Zwillich, S. H.; Wang, T.; Rottinghaus, S.; Kawabata, T.; Riese, R.; Mebus, C.; Bradley, J. D.; Bingham, C. O. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0153 Improvements in disease activity score by baseline status: Pooled analysis of five phase 3 studies with tofacitinib (CP-690, 550) in patients with active rheumatoid arthritis. (23rd January 2014) Authors: Fleischmann, R.M.; Krishnaswami, S.; Gruben, D.; Zwillich, S.H.; Mebus, C.; Bradley, J.D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0228 Tofacitinib, an Oral Janus Kinase Inhibitor: Post-HOC Analyses of Efficacy and Safety of Monotherapy Versus Combination Therapy in a Phase 3 Rheumatoid Arthritis Population. (23rd January 2014) Authors: Keystone, E.; Fleischmann, R.; van Vollenhoven, R.; Kremer, J.; Gruben, D.; Bradley, J.; Riese, R.; Mebus, C.; Wallenstein, G.; Zwillich, S. H.; Benda, B.; Krishnaswami, S. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Unilateral sagittal split ramus osteotomy: an alternative for some cases of asymmetric mandibular prognathism. Issue 5 (May 2018) Authors: Fariña, R.; Mebus, C.; Mayer, C.; Torrealba, R.; Moreno, E. Journal: International journal of oral & maxillofacial surgery Issue: Volume 47:Issue 5(2018:May) Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗